Stereotaxis, Inc. (STXS)
NYSEAMERICAN: STXS · Real-Time Price · USD
2.310
+0.090 (4.05%)
At close: Dec 20, 2024, 3:51 PM
2.390
+0.080 (3.46%)
After-hours: Dec 20, 2024, 7:56 PM EST
Stereotaxis Employees
Stereotaxis had 122 employees as of December 31, 2023. The number of employees decreased by 8 or -6.15% compared to the previous year.
Employees
122
Change (1Y)
-8
Growth (1Y)
-6.15%
Revenue / Employee
$206,090
Profits / Employee
-$187,648
Market Cap
199.11M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Organigram Holdings | 984 |
Inogen | 834 |
MacroGenics | 339 |
Inventiva | 123 |
Mersana Therapeutics | 123 |
Perspective Therapeutics | 119 |
Atai Life Sciences | 83 |
XBiotech | 82 |
STXS News
- 12 days ago - Magbot Robotic Magnetic Navigation Ablation Catheter Approved by China's NMPA - GlobeNewsWire
- 19 days ago - Stereotaxis' GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical Systems - GlobeNewsWire
- 20 days ago - Stereotaxis To Drive Transformational Growth Via Full Ecosystem Launch In 2025 - Seeking Alpha
- 25 days ago - Stereotaxis to Participate in Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 26 days ago - Stereotaxis Genesis Robotic System Achieves Regulatory Approval in China - GlobeNewsWire
- 4 weeks ago - Hospital Da Luz is the First in Portugal to Adopt Genesis Robotic System - GlobeNewsWire
- 5 weeks ago - Stereotaxis, Inc. (STXS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Stereotaxis Reports 2024 Third Quarter Financial Results - GlobeNewsWire